EpiCast Report: Sepsis and Septic Shock - Epidemiology Forecast to 2026

Sepsis is a life-threatening complication arising from an infection, which occurs when the body's response to the infection damages its own tissues and organs. Sepsis can lead to multiple organ failure and death, especially if it is not recognized early and treated promptly (Elfeky et al., 2017; Mayo Clinic, 2016). Anyone can develop sepsis; however, the condition is more common among children less than one year of age, older adults, and those with weakened immune systems (Elfeky et al., 2017; Mayo Clinic, 2016).

In men and women, among the 7MM in 2016, the US had the highest age-standardized diagnosed incidence of sepsis and Japan had the lowest. In the 5EU (France, Germany, Italy, Spain, UK), the age-standardized diagnosed incidence of sepsis in men ranged between 94.91 cases per 100,000 population in France and 174.05 cases per 100,000 population in the UK in 2016. The age-standardized diagnosed incidence of sepsis in women in the 5EU ranged between 36.76 cases per 100,000 population in France and 128.05 cases per 100,000 populations in the UK in 2016. Due to data scarcity, the crude diagnosed incidence of sepsis for Italy is considered to be same as that of Spain and therefore the calculated age-standardized diagnosed incidence rates are also similar in these markets.

Among the 7MM, in men and women in 2016, the US had the highest age-standardized diagnosed incidence of septic shock and Japan had the lowest. In the 5EU, the age-standardized diagnosed incidence of sepsis in men ranged between 29.55 cases per 100,000 population in Germany and 52.57 cases per 100,000 population in the UK in 2016. Similarly, the age-standardized diagnosed incidence of septic shock in women in the 5EU ranged between 11.56 cases per 100,000 population in France and 38.86 cases per 100,000 population in the UK in 2016. Due to data scarcity, the crude diagnosed incidence of septic shock for Italy is considered to be same as that of Spain and therefore, the calculated age-standardized diagnosed incidence rates are also similar in these markets.

The report "EpiCast Report: Sepsis and Septic Shock - Epidemiology Forecast to 2026", provides an overview of the risk factors, comorbidities, and the global and historical trends for sepsis and septic shock in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). The report includes a 10-year epidemiological forecast for the diagnosed incident cases of sepsis and septic shock, segmented by sex and by age (for all ages).

In depth, this report provides the following -

• The sepsis and septic shock epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
• The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Scope:

• The Sepsis and Septic Shock EpiCast Report provides an overview of the risk factors and global trends of sepsis and septic shock in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of sepsis and septic shock, segmented by age (for all ages) and sex. The sepsis and septic shock diagnosed incident cases are further segmented by causative agent and organ dysfunction. Additionally, GlobalData epidemiologists provide a forecast for the in-hospital mortality cases of sepsis and septic shock, segmented by age for both sexes.
• The sepsis and septic shock epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
• The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy:

The Sepsis and Septic Shock EpiCast report will allow you to -

• Develop business strategies by understanding the trends shaping and driving the global sepsis and septic shock market.
• Quantify patient populations in the global sepsis and septic shock market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for sepsis and septic shock therapeutics in each of the markets covered.
• Understand the causative agent, organ dysfunction, and mortality of sepsis and septic shock.

Table of Contents

1. Table of Contents

• 1.1. List of Tables
• 1.2. List of Figures

2. Executive Summary

• 2.1. Related Reports
• 2.2. Upcoming Reports

3. Epidemiology

• 3.1. Disease Background
• 3.2. Risk Factors and Comorbidities
• 3.3. Global and Historical Trends
• 3.4. Forecast Methodology
  • 3.4.1. Sources
  • 3.4.2. Forecast Assumptions and Methods
  • 3.4.3. Diagnosed Incident Cases of Sepsis
  • 3.4.4. Diagnosed Incident Cases of Septic Shock
  • 3.4.5. Diagnosed Incident Cases of Sepsis/Septic Shock by Causative Agent
  • 3.4.6. Organ Dysfunction among Diagnosed Incident Cases of Sepsis
  • 3.4.7. Organ Dysfunction among Diagnosed Incident Cases of Septic Shock
  • 3.4.8. Sepsis In-Hospital Mortality Cases
  • 3.4.9. Septic Shock In-Hospital Mortality Cases
• 3.5. Epidemiological Forecast for Sepsis and Septic Shock (2016-2026)
  • 3.5.1. Diagnosed Incident Cases of Sepsis
  • 3.5.2. Age-Specific Diagnosed Incident Cases of Sepsis
  • 3.5.3. Sex-Specific Diagnosed Incident Cases of Sepsis
  • 3.5.4. Diagnosed Incident Cases of Sepsis by Causative Agent
  • 3.5.5. Organ Dysfunction among Diagnosed Incident Cases of Sepsis
  • 3.5.6. Sepsis In-Hospital Mortality Cases
  • 3.5.7. Age-Specific In-Hospital Mortality Cases of Sepsis
  • 3.5.8. Diagnosed Incident Cases of Septic Shock
  • 3.5.9. Age-Specific Diagnosed Incident Cases of Septic Shock
  • 3.5.10. Sex-Specific Diagnosed Incident Cases of Septic Shock
  • 3.5.11. Diagnosed Incident Cases of Septic Shock by Causative Agent
  • 3.5.12. Organ Dysfunction among Diagnosed Incident Cases of Septic Shock
  • 3.5.13. Septic Shock In-Hospital Mortality Cases
  • 3.5.14. Age-Specific In-Hospital Mortality Cases of Septic Shock
• 3.6. Discussion
  • 3.6.1. Epidemiological Forecast Insight
  • 3.6.2. Limitations of Analysis
  • 3.6.3. Strengths of Analysis

4. Appendix

• 4.1. Bibliography
• 4.2. About the Authors
  • 4.2.1. Epidemiologist
  • 4.2.2. Reviewers
  • 4.2.3. Global Director of Therapy Analysis and Epidemiology
  • 4.2.4. Global Head and EVP of Healthcare Operations and Strategy
• 4.3. About GlobalData
• 4.4. Contact Us
• 4.5. Disclaimer

List of Tables

• Table 1: Risk Factors and Comorbidities for Sepsis and Septic Shock
• Table 2: 7MM, Diagnosed Incident Cases of Sepsis, Both Sexes, All Ages, Selected Years 2016-2026
• Table 3: 7MM, Sepsis In-Hospital Mortality Cases, Both Sexes, All Ages, Selected Years 2016-2026
• Table 4: 7MM, Diagnosed Incident Cases of Septic Shock, Both Sexes, All Ages, Selected Years 2016-2026
• Table 5: 7MM, Septic Shock In-Hospital Mortality Cases, Both Sexes, All Ages, Selected Years 2016-2026

List of Figures

• Figure 1: 7MM, Diagnosed Incident Cases of Sepsis, Both Sexes, All Ages, 2016 and 2026
• Figure 2: 7MM, Diagnosed Incident Cases of Septic Shock, Both Sexes, All Ages, 2016 and 2026
• Figure 3: 7MM, Age-Standardized Diagnosed Incidence of Sepsis (Cases per 100,000 Population), Both Sexes, All Ages, 2016
• Figure 4: 7MM, Age-Standardized Diagnosed Incidence of Septic Shock (Cases per 100,000 Population), Both Sexes, All Ages, 2016
• Figure 5: 7MM, Sources Used and Not Used, Diagnosed Incident Cases of Sepsis
• Figure 6: 7MM, Sources Used and Not Used, Diagnosed Incident Cases of Sepsis/Septic Shock by Causative Agent
• Figure 7: 7MM, Sources Used and Not Used, Organ Dysfunction among Sepsis Cases
• Figure 8: 7MM, Sources Used and Not Used, In-Hospital Mortality Cases of Sepsis
• Figure 9: 7MM, Sources Used and Not Used, Diagnosed Incident Cases of Septic Shock
• Figure 10: 7MM, Sources Used and Not Used, Organ Dysfunction of Septic Shock Cases
• Figure 11: 7MM, Sources Used, In-Hospital Mortality Cases of Septic Shock
• Figure 12: 7MM, Age-Specific Diagnosed Incident Cases of Sepsis, Both Sexes, All Ages, 2016
• Figure 13: 7MM, Sex-Specific Diagnosed Incident Cases of Sepsis, Both Sexes, All Ages, 2016
• Figure 14: 7MM, Diagnosed Incident Cases of Sepsis by Causative Agent, Both Sexes, All Ages, 2016
• Figure 15: 7MM, Organ Dysfunction among Diagnosed Incident Cases of Sepsis, Both Sexes, All Ages, 2016
• Figure 16: 7MM, Age-Specific In-Hospital Mortality Cases of Sepsis, Both Sexes, All Ages, 2016
• Figure 17: 7MM, Age-Specific Diagnosed Incident Cases of Septic Shock, Both Sexes, All Ages, 2016
• Figure 18: 7MM, Sex-Specific Diagnosed Incident Cases of Septic Shock, Both Sexes, All Ages, 2016
• Figure 19: 7MM, Diagnosed Incident Cases of Septic Shock by Causative Agent, Both Sexes, All Ages, 2016
• Figure 20: 7MM, Organ Dysfunction among Diagnosed Incident Cases of Septic Shock, Both Sexes, All Ages, 2016
• Figure 21: 7MM, Age-Specific In-Hospital Mortality Cases of Septic Shock, Both Sexes, All Ages, 2016